In summary, these results demonstrate that a specific population of cultured human fetal heart-derived fibroblasts expressing VCAM1 has a role in lymphangiogenesis, and that a treatment with VCFs restores cardiac contractile functions on heart failure following myocardial infarction by mobilizing lymph endothelial cells into the infarct. Here, VCAM1 is linked to myocardial infarction.